Hayakawa H, Abe A, Momose M, Kubo H, Suzuki M, Kawaguchi Y, Sakai O
Department of Internal Medicine (II), Jikei University School of Medicine, Tokyo, Japan.
Nihon Jinzo Gakkai Shi. 1996 Nov;38(11):530-4.
A 30-year-old woman with chronic renal failure (CRF) due to glycogen storage disease Type I (GSD I) was admitted for dialysis. Hemodialysis (HD) was introduced as the primary therapeutic modality. However, maintenance HD was very difficult to conduct because of hypotension during the HD sessions. Furthermore, hypoglycemia and metabolic disturbances persisted. After changing from HD to CAPD, fasting blood sugar was significantly elevated through a continuous glucose supply from the dialysate. The values of ketone, non-esterified fatty acid, blood urea nitrogen/creatinine (BUN/ Cr), and glucagon were improved. CAPD not only controlled uremia, but also ameliorated the metabolic disturbances of GSD I. Therefore, we conclude that CAPD is superior to HD as a dialytic modality for patients with CRF due to GSD I.
一名因I型糖原贮积病(GSD I)导致慢性肾衰竭(CRF)的30岁女性因透析入院。血液透析(HD)被作为主要治疗方式引入。然而,由于血液透析过程中出现低血压,维持性血液透析很难进行。此外,低血糖和代谢紊乱持续存在。从血液透析改为持续性非卧床腹膜透析(CAPD)后,通过透析液持续供应葡萄糖,空腹血糖显著升高。酮体、非酯化脂肪酸、血尿素氮/肌酐(BUN/Cr)和胰高血糖素的值均得到改善。CAPD不仅控制了尿毒症,还改善了GSD I的代谢紊乱。因此,我们得出结论,对于因GSD I导致慢性肾衰竭的患者,CAPD作为一种透析方式优于HD。